当前位置:首页 - 行情中心 - 博瑞医药(688166) - 财务分析

博瑞医药

(688166)

  

流通市值:130.63亿  总市值:130.63亿
流通股本:4.22亿   总股本:4.22亿

博瑞医药(688166)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润1.47亿元,每股收益0.42元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益234233.97万元,未分配利润96732.63万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产487853.28万元,负债253619.31万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入976,825,695.67657,688,446.99340,133,145.781,179,517,532.47
营业总成本798,339,394.77554,212,734.85267,341,183.31980,322,905.2
营业利润168,350,913.5294,397,237.8370,691,727.53190,244,378.17
利润总额168,076,343.1494,306,260.2870,586,962.95188,770,059.91
净利润146,757,526.8482,226,988.6461,809,832.36173,423,636.78
其他综合收益-35,070,709.12-35,136,666.18-2,285,122.48-26,399,481.11
综合收益总额111,686,817.7247,090,322.4659,524,709.88147,024,155.67
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计1,382,517,329.281,737,952,788.591,776,422,797.851,839,738,327.73
非流动资产合计3,496,015,482.523,492,715,373.253,311,084,092.563,192,093,048.19
资产总计4,878,532,811.85,230,668,161.845,087,506,890.415,031,831,375.92
流动负债合计885,484,629.781,013,104,881.12999,303,115.94922,247,516.28
非流动负债合计1,650,708,519.231,803,420,334.281,614,038,634.41,692,000,312.71
负债合计2,536,193,149.012,816,525,215.42,613,341,750.342,614,247,828.99
归属于母公司股东权益合计2,352,381,122.672,387,662,549.132,427,457,083.492,368,615,404
股东权益合计2,342,339,662.792,414,142,946.442,474,165,140.072,417,583,546.93
负债和股东权益合计4,878,532,811.85,230,668,161.845,087,506,890.415,031,831,375.92
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计904,023,277.15639,396,541.41375,723,006.991,075,884,896.39
经营活动现金流出小计784,433,575.12488,176,192.29227,261,236.07881,119,430.34
经营活动产生的现金流量净额119,589,702.03151,220,349.12148,461,770.92194,765,466.05
投资活动现金流入小计98,281,859.0987,669,492.94-133,903,466.89
投资活动现金流出小计523,154,996.71379,415,238.28138,378,675.23573,757,024.66
投资活动产生的现金流量净额-424,873,137.62-291,745,745.34-138,378,675.23-439,853,557.77
筹资活动现金流入小计595,962,819.75516,062,819.75262,946,563.35746,232,414.46
筹资活动现金流出小计769,729,870.72400,369,380.25273,917,979.83684,621,214.2
筹资活动产生的现金流量净额-173,767,050.97115,693,439.5-10,971,416.4861,611,200.26
汇率变动对现金及现金等价物的影响1,333,672.341,913,878.09809,432.552,782,675.14
现金及现金等价物净增加额-477,716,814.22-22,918,078.63-78,888.24-180,694,216.32
期末现金及现金等价物余额493,323,980.01948,122,715.6970,961,905.99971,040,794.23
最新报告期:2024-12-02
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
东吴证券朱国广0.490.610.702024-12-02
华西证券崔文亮0.520.610.692024-11-11
国盛证券张金洋,胡偌碧,陈欣黎0.500.550.702024-11-04
TOP↑